Regulation & Compliance

360 Delaware customers get a new water provider as Tidewater Utilities' acquisition highlights a trend of utility consolidation and promises service upgrades.

Tevogen Bio's stock surged on news of a potential special dividend, but a closer look reveals a risky promise from a pre-revenue firm facing major hurdles.

The CFP Board disciplined nine individuals, revoking certifications for roles in a Ponzi scheme and fraud, reinforcing its role as an ethical watchdog.

Corcept Therapeutics' stock plummeted and it now faces legal probes after the FDA rejected its key drug, revealing the company was warned not to apply.

Promising Phase 2 data for a potential first-in-class neuropathic corneal pain therapy to be showcased, offering new hope for a debilitating condition.

Asante Gold boosts its war chest with a C$13.8M private placement led by its own chairman, fueling aggressive expansion at its Ghanaian gold mines.

Incyte's Zynyz gets a key EU panel's nod, offering a breakthrough for advanced anal canal cancer patients after decades of limited treatment options.

Enterprises are stuck in AI pilot mode. A new generation of startups is breaking the logjam with solutions for data, training, and compliance.

With backing from a top hospital, VolitionRx seeks reimbursement for its Nu.Q® blood test, aiming to transform lung cancer care in France and beyond.

With a $150M partnership, Nada and Medalist are betting big on Home Equity Agreements. Is this the future for homeowners seeking cash without debt?

Ad tech firm Publift achieves Google's top-tier Premier Partner status, promising enhanced revenue and strategic support for publishers in a changing ad landscape.

A key expansion order validates Actelis' hybrid network tech, helping a major energy operator modernize its critical infrastructure against new cyber risks.

An Austin-based tech company's platform, which integrates into doctors' workflows, has cut prescription costs for nearly 60,000 Ohio residents.

Ritholtz Wealth Management defies industry trends by expanding ownership to 29 employees, cementing its independence in an era of private equity deals.

Following a top wallet award, XBITU's new integration with Apple Pay and Google Pay could finally make spending your crypto as easy as using a credit card.

A major real-world study shows physician-led medical cannabis use improves pain, anxiety, and quality of life, adding key evidence to the field.

CIRM's new RAPID program aims to revolutionize genetic therapy, using scalable platforms to bring hope to millions with rare diseases who have no options.

Alberta’s innovative permit system is hailed as a model for Canada, but critics question if speed comes at a cost. See who else is fighting red tape.

Publicly-traded xTAO Inc. upgrades its infrastructure, securing a top spot in Bittensor's high-stakes decentralized AI ecosystem. What does this mean for the future?

The market for drugs like Ozempic and Wegovy is set to explode, fueled by new oral pills, expanded uses for heart and liver disease, and fierce competition.